Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders

British Journal of Oral and Maxillofacial Surgery

Volumn 40, Issue 5, 2002, Pages 418-423

  Kaneyama, K ^a,b   Segami, N ^a   Nishimura, M ^a   Suzuki, T ^a   Sato, J ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JOINT DEGENERATION; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; SYMPTOMATOLOGY; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDER; VOLUNTEER;

EID: 0036774440     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0266-4356(02)00215-2     Document Type: Article

References (22)

1. Fong KY, Boey ML, Koh WH, Feng PH. Cytokine concentrations in the synovial fluid and plasma of rheumatoid arthritis patients: correlation with bony erosions. Clin Exp Rheumatol 1994; 12: 55-58.
2. Sinmei M, Masuda K, Kikuchi T, Shimomura Y. Interleukin 1, tumor necrosis factor, and interleukin 6 as mediators of cartilage destruction. Semin Arthritis Rheum 1989; 18: 27-32.
3. Neidel J, Schulze M, Lindschau J. Association between bone-erosion and synovial fluid of tumor necrosis factor α in the knee-joints of patients with rheumatoid arthritis. Inflamm Res 1995; 44: 217-221.
4. Lotz M, Terkeltaub R, Villiger PM. Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J Immunol 1992; 148: 466-473.
5. William P. Dayer JM. Inhibition of the production and effect of interleukin- 1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995; 38: 151-160.
6. Wilbrink B, Nietfeld J, Otter W, Bijlsma JW, Huber-Bruning O. Role of TNFα in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br J Rheumatol 1991; 30: 265-271.
7. Nietfeld JJ, Wilbrink B, Helle M et al. Interleukin- 1 -induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin- 1 in human articular cartilage. Arthritis Rheum 1990; 33: 1695-1701.
8. Kubota E, Immamura H, Kubota T, Shibata T, Murakami K. Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997; 55: 20-27.
9. Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol 1998; 85: 135-141.
10. Fu K, Ma X, Zhang Z, Pang X, Chen W. Interleukin-6 in synovial fluid and Hla-DF expression synovium from patients with temporomandibular disorders. J Orofac Pain 1995; 9: 131-137.
11. Shafer DM, Assael L, White LB, Edward FR. Tumor necrosis factor-α as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg 1994; 52: 786-791.
12. Fu K, Ma XC, Zhang Z, Chen W. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 1995; 53: 424-426.
13. Sandler NA, Buckley MJ, Cillo JE, Thomas WB. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements. J Oral Maxillofac Surg 1998; 56: 534-543.
14. Suzuki T, Segami N, Kaneyama K, Nishimura M, Nojima T. Specific expression of interleukin- 1β in the temporomandibular joints with internal derangement: correlation with clinical findings. Oral Surg Oral Med Oral Pathol 1999; 88: 413-417.
15. Larsen CG, Anderson AO, Appelia E, Oppenheim JJ, Matsushima K. The neutrophil -activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243: 1464-1466.
16. Hirano T, Matsuda T, Turner M, Miyasaka N. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988; 18: 1797-1801.
17. Kopp S, Wenneberg B, Clemensson E. Clinical microscopical and biochemical investigation of synovial fluid from temporomandibular joints. Scand J Dent Res 1983; 91: 33-41.
18. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33: 305-315.
19. Cush JJ, Spalawski JB, Thomas R, Mcfarlin JE. Elevated interleukin- 10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 96-104.
20. Malyak M, Swaney RE, Arend WP. Levels of synovial fluid interleukin- 1 receptor antagonist in rheumatoid arthritis and other arthropathies. Arthritis Rheum 1993; 36: 781-789.
21. Fang P-K, Ma XC, Ma DL, Fu K. Determination of interleukin- 1 receptor antagonist, interleukin-10, and transforming growth factor-β in synovial fluid aspirates of patients with temporomandibular disorders. J Oral Maxillofac Surg 1999: 57: 922-928.
22. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992; 35: 1160-1169.